Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 75: 185-190, 1993;
8750-7587/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawano, O.
Right arrow Articles by Ando, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawano, O.
Right arrow Articles by Ando, M.

Journal of Applied Physiology, Vol 75, Issue 1 185-190, Copyright © 1993 by American Physiological Society

ARTICLES

Neutral endopeptidase inhibitor potentiates allergic bronchoconstriction in guinea pigs in vivo

O. Kawano, H. Kohrogi, T. Yamaguchi, S. Araki and M. Ando
First Department of Internal Medicine, Kumamoto University School of Medicine, Japan.

To determine whether endogenous tachykinins are released in allergic airway response to contribute to bronchoconstriction and whether neutral endopeptidase (NEP), which effectively cleaves tachykinins, modulates that bronchoconstriction, we studied the effects of the NEP inhibitor phosphoramidon on bronchoconstriction induced by allergic response in anesthetized guinea pigs. We mechanically ventilated the guinea pigs sensitized with ovalbumin (OVA) in a bodyplethysmograph and measured the pulmonary resistance (RL). We exposed the sensitized guinea pigs to doubling concentrations of OVA aerosols from 2(-5)% (wt/vol) until the transpulmonary pressure increased more than twofold from the baseline. After the final exposure, we exposed them to phosphoramidon (10(-4) M) or its vehicle. Phosphoramidon significantly potentiated the increased RL induced by OVA challenge. Phosphoramidon also significantly potentiated the increased RL in the guinea pigs treated with atropine, but the potentiation was significantly reduced. In contrast, phosphoramidon failed to potentiate the increased RL induced by OVA in guinea pigs pretreated with capsaicin. These results suggest that 1) endogenous tachykinin-like substances are released in allergic airway response and that 2) when endogenous NEP is inhibited in the guinea pig airways in vivo, the substances contribute to bronchoconstriction by partly activating the parasympathetic nerve.


This article has been cited by other articles:


Home page
 Am. J. Respir. Cell Mol. Bio.Home page
G. W. Hoyle, R. M. Graham, J. B. Finkelstein, K.-P. T. Nguyen, D. Gozal, and M. Friedman
Hyperinnervation of the Airways in Transgenic Mice Overexpressing Nerve Growth Factor
Am. J. Respir. Cell Mol. Biol., February 1, 1998; 18(2): 149 - 157.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Garland, J. Necheles, S. R. White, S. P. Neeley, A. R. Leff, S. S. Carson, L. E. Alger, K. McAllister, and J. Solway
Activated eosinophils elicit substance P release from cultured dorsal root ganglion neurons
Am J Physiol Lung Cell Mol Physiol, November 1, 1997; 273(5): L1096 - L1102.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
X. X. Yang, W. S. Powell, M. Hojo, and J. G. Martin
Hyperpnea-induced bronchoconstriction is dependent on tachykinin-induced cysteinyl leukotriene synthesis
J Appl Physiol, February 1, 1997; 82(2): 538 - 544.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online